340B Drug Pricing Program
The AHA today urged the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program.
The AHA urges the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program.
On Nov. 2, the Centers for Medicare & Medicaid Services issued its calendar year 2019 outpatient prospective payment system /ambulatory surgical center final rule. In addition to standard updates, the rule expands Medicare 鈥渟ite-neutral鈥 payment policies and changes the payment policies for鈥
Facing deadlines for responding to the lawsuit brought by the AHA, Association of American Medical Colleges, America's Essential Hospitals, 340B Health and three hospital systems, the Health Resources and Services Administration proposes a Jan. 1 compliance date for its final rule on 340B drug鈥
A federal court today denied the Department of Health and Human Services鈥 motion for a stay in a lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.
Tom Nickels
Executive Vice President
The Department of Health and Human Services today proposed implementing on Jan. 1 its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Melinda Hatton
On October 25, the Centers for Medicare & Medicaid Services issued an advance notice of proposed rulemaking to solicit public comments on potential options for testing a new model for paying for prescription drugs under Medicare Part B provided in physician offices, hospital outpatient鈥